Research and Markets (http://www.researchandmarkets.com/research/601374/the_top_60_europea) has announced the addition of the "The Top 60 European Manufacturers Of Generic Pharmaceuticals" report to their offering.
Did you know?
- Generic medicines make up nearly 50% of all medicines dispensed in the EU, and account for 18% of pharmaceutical spending.
- Generic medicines save EU patients and healthcare systems euro25 billion every year.
- There are more than 700 generic companies in Europe employing 130,000 staff.
The European generic medicines industry makes a major contribution to European healthcare by providing cost-effective treatment for many of today's most common illnesses and conditions, such as cancer, diabetes, depression and high blood pressure. Providing sustainable treatment for these illnesses, which are particularly prevalent in older patients, is becoming increasingly difficult as Europe's population ages. In fact, the rapidly ageing population in Europe, the increase in the prevalence of certain diseases and the rise in prices for originator pharmaceuticals are creating a critical need for more generic medicines.
This report profiles the Top 60 European generic pharmaceutical manufacturers. These major companies have the experience, know-how and resources that enable them to identify patented products and make them available as a generic on the day of patent expiry. They manufacture multiple products in various dosage forms and in a wide variety of therapeutic classes and export them across the globe.
Profile information for each company in The Top 60 European Generic Pharmaceutical Manufacturers typically includes: